scispace - formally typeset
K

Kelly Jean Thomas

Researcher at National Institutes of Health

Publications -  24
Citations -  8667

Kelly Jean Thomas is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Mitochondrion & PINK1. The author has an hindex of 18, co-authored 24 publications receiving 7943 citations. Previous affiliations of Kelly Jean Thomas include Brigham and Women's Hospital & St Mary's Hospital.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

TL;DR: Manipulating activity by replacing the kinase domain with a 'kinase-dead' version blocks inclusion body formation and strongly delays cell death, predicting that kinase inhibitors will be useful therapeutic agents in patients with LRRK2 mutations and, perhaps, in sporadic PD.
Journal ArticleDOI

DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy

TL;DR: It is shown that loss of DJ-1 leads to loss of mitochondrial polarization, fragmentation of mitochondria and accumulation of markers of autophagy around mitochondria in human dopaminergic cells, and data suggest thatDJ-1 works in parallel to the PINK1/parkin pathway to maintain mitochondrial function in the presence of an oxidative environment.
Journal ArticleDOI

Mitochondrial function and morphology are impaired in parkin mutant fibroblasts

TL;DR: The aim of this study was to determine mitochondrial function and morphology in parkin‐mutant patients and to investigate whether pharmacological rescue of impaired mitochondrial function may be possible in Parkin‐Mutant human tissue.
Journal ArticleDOI

The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation

TL;DR: It is shown that L RRK2 predominantly exists as a dimer under native conditions, a state that appears to be stabilized by multiple domain-domain interactions and it is demonstrated that LRRK2 undergoes intramolecular autophosphorylation.